Beata Filip-Psurska

9PUBLICATIONS
25CO-AUTHORS
Molecular targetsHaematological tumoursBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2026
Ultrasound-Assisted Synthesis and Biological Profiling of 1,3,5-Triazine Derivatives with Antiproliferative Activity in Triple-Negative Breast Cancer.

Natalia Bosak, Anna Karolina Drabczyk, Jolanta Jaśkowska

|Jan 11, 2024
Age-Dependent Effect of Calcitriol on Mouse Regulatory T and B Lymphocytes.

Agata Śnieżewska, Artur Anisiewicz, Katarzyna Gdesz-Birula

|Apr 28, 2023
Prenylated Flavonoids with Selective Toxicity against Human Cancers.

Tomasz Tronina, Agnieszka Bartmańska, Jarosław Popłoński

|Aug 12, 2022
Vitamin D, Th17 Lymphocytes, and Breast Cancer.

Beata Filip-Psurska, Honorata Zachary, Aleksandra Strzykalska

|Jun 14, 2022
Combined anticancer therapy with imidazoacridinone analogue C-1305 and paclitaxel in human lung and colon cancer xenografts-Modulation of tumour angiogenesis.

Marta Świtalska, Beata Filip-Psurska, Magdalena Milczarek

|Apr 03, 2021
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.

Beata Filip-Psurska, Mateusz Psurski, Artur Anisiewicz

Pageof 2